Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2009

Dec 28, 2009

30339_dirs_2009-12-28_041032e6-20c2-450f-86af-d097b097abab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-12-23

Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-12-23 Common Stock M 25000 $13.0157 Acquired 61145.5525 Direct
2009-12-23 Common Stock F 15031.23 $39.57 Disposed 46114.3225 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-12-23 Stock Option (Right to Buy) $13.0157 M 25000 Disposed 2010-03-25 Common Stock (25000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 424.5911 Indirect
Common Stock 4553.5937 Indirect